Georgia Tech Releases Machine Learning Software to Further Cancer Drug Research

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

External News Details
Media
  • Fredrik Vannberg Fredrik Vannberg
    (image/jpeg)
  • John McDonald John McDonald
    (image/jpeg)

HealthTech focuses on the recent news that School of Biological Sciences researchers are allowing all scientists to use their new machine learning software for predicting cancer drug effectiveness. The hope is that the open source software approach, which will crowdsource research brainpower and expertise, will speed up the clinical trials process for cancer drug approval. Assistant Professor Fredrik Vannberg and Professor John McDonald contributed to the research; McDonald is also director of Tech's Integrated Cancer Research Center.

Additional Information

Groups

College of Sciences, School of Biological Sciences

Categories
Life Sciences and Biology
Keywords
College of Sciences, School of Biological Sciences, John McDonald, Fredrik Vannberg, Cancer research, cancer drugs, open source software, machine learning
Status
  • Created By: Renay San Miguel
  • Workflow Status: Published
  • Created On: Dec 1, 2017 - 12:25pm
  • Last Updated: Dec 1, 2017 - 12:28pm